Inotiv Inc (NASDAQ:NOTV)
| 7.45 Delayed Data As of Jan 27 |  +0.65 / +9.56%Today’s Change | 3.65 Today|||52-Week Range 42.63 | +50.81% Year-to-Date |
| SECTOR Commercial Services | INDUSTRY Miscellaneous Commercial Services | MARKET CAP $169.3M |
Company Description
Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Research Services and Research Products. The Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Contact Information
Inotiv, Inc. 2701 Kent Avenue West Lafayette Indiana 47906-1382 |
Employees
Shareholders
| Other institutional | 27.97% |
| Individual stakeholders | 20.93% |
| Mutual fund holders | 18.89% |
Top Executives
| Robert Leasure | President, Chief Executive Officer & Director |
| John Gregory Beattie | COO-Discovery & Development Services |
| Beth A. Taylor | Chief Financial Officer & Senior Vice President |
| Mo Dastagir | Chief Technology Officer |
| Adrian Hardy | Executive Vice President |
